{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:29:55Z","timestamp":1649057395399},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,15]]},"DOI":"10.2146\/ajhp110043","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T22:06:47Z","timestamp":1314828407000},"page":"1711-1715","source":"Crossref","is-referenced-by-count":0,"title":["Readministration of drotrecogin alfa (activated) in an adult with severe sepsis"],"prefix":"10.1093","volume":"68","author":[{"given":"Marco R.","family":"Scipione","sequence":"first","affiliation":[{"name":"Division of Pharmacotherapy, New York University Langone Medical Center, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Nogid","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Davanos","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"DiGregorio","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041106052778900_b1-0681711","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/00003246-200111000-00003","article-title":"Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis","volume":"29","author":"Bernard","year":"2001","journal-title":"Crit Care Med."},{"key":"key\n\t\t\t\t2019041106052778900_b2-0681711","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4037\/ajcc2003.12.6.518","article-title":"Role of activated protein C in the pathophysiology of severe sepsis","volume":"12","author":"Dettenmeier","year":"2003","journal-title":"Am J Crit Care."},{"key":"key\n\t\t\t\t2019041106052778900_b3-0681711","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med."},{"key":"key\n\t\t\t\t2019041106052778900_b4-0681711","volume-title":"Xigris (drotrecogin alfa [activated]) package insert","year":"2007"},{"key":"key\n\t\t\t\t2019041106052778900_b5-0681711","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CCM.0b013e318192843b","article-title":"Adverse outcomes associated with the use of drotrecogin alfa (activated) in patients with severe sepsis and baseline bleeding precautions","volume":"37","author":"Gentry","year":"2009","journal-title":"Crit Care Med."},{"key":"key\n\t\t\t\t2019041106052778900_b6-0681711","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/CCM.0b013e3181935102","article-title":"Recombinant human activated protein C, package labeling, and hemorrhage risks","volume":"37","author":"Sweeney","year":"2009","journal-title":"Crit Care Med."},{"key":"key\n\t\t\t\t2019041106052778900_b7-0681711","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041106052778900_b8-0681711","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V94.3.895.415k01_895_901","article-title":"Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C","volume":"94","author":"Zivelin","year":"1999","journal-title":"Blood."},{"key":"key\n\t\t\t\t2019041106052778900_b9-0681711","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1538-7836.2009.03601.x","article-title":"Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alfa (activated)","volume":"7","author":"Yan","year":"2009","journal-title":"J Thromb Haemost."},{"key":"key\n\t\t\t\t2019041106052778900_b10-0681711","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1130-6343(06)73971-X","article-title":"[Readministration of drotrecogin alfa in a patient with Crohn\u2019s disease.]","volume":"30","author":"Cid Conde","year":"2006","journal-title":"Farm Hosp"},{"key":"key\n\t\t\t\t2019041106052778900_b11-0681711","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/01.ta.0000195999.18928.dc","article-title":"Second course of recombinant human activated protein C delivered to a severely septic patient after recent surgery","volume":"64","author":"Lee","year":"2008","journal-title":"J Trauma."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/18\/1711\/28350237\/ajhp1711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T23:21:56Z","timestamp":1592868116000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/18\/1711\/5129251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":11,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,9,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110043","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,9,15]]},"published":{"date-parts":[[2011,9,15]]}}}